Search Lavipharm.com

 

Regulated Information

  Lavipharm S.A. announces, according to Ν.3556/2007, 1/434/3.7.2007 and Circular 33 of the Board of Directors of the Capital Market Committee, that on 18/5/2009, Μr. Christos Kartalis, son of Dimitrios, Group Chief Commercial Officer of Lavipharm, purchased 70.000 common Lavipharm shares, amounting to 115.000,00 euros....